Skip to content

DocGo DCGO Payments to acquire equity securities

Payments to acquire equity securities at other companies

First American Financial logo
First American FinancialFAF
$29.7M+75.7%
UBS
United BanksharesUBSI
$4.17M+4,239%
Community Financial System logo
Community Financial SystemCBU
$5.62M+8,814%
The Hanover Insurance Group logo
The Hanover Insurance GroupTHG
$12.9M-37.7%
BancFirst Corporation logo
BancFirst CorporationBANF
$214K-16.4%
M&T Bank logo
M&T BankMTB
$579M+320%

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept dcgo:PaymentsToAcquireEquitySecuritiesWithoutReadilyDeterminableFairValue.

The official record: DocGo’s 10-K, filed March 16, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's payments to acquire equity securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's payments to acquire equity securities?
DocGo (DCGO) reported payments to acquire equity securities of $0 in Q4 2025.
How has DocGo's payments to acquire equity securities changed year-over-year?
DocGo's payments to acquire equity securities decreased by 100.0% year-over-year, from $1.25M to $0.
What does payments to acquire equity securities mean?
This represents cash outflows for the acquisition of equity stakes in other companies where there is no readily determinable market price. These investments are typically strategic in nature, aimed at fostering partnerships or gaining access to new technologies and markets. It reflects the company's strategy for inorganic growth and long-term value creation through external ventures.